Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-256-4 | CAS number: 27138-01-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- G.I. human passive absorption
- Type of information:
- calculation (if not (Q)SAR)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a (Q)SAR model, with limited documentation / justification, but validity of model and reliability of prediction considered adequate based on a generally acknowledged source
- Objective of study:
- absorption
- Guideline:
- other: REACH Guidance on QSARs R.6
- Principles of method if other than guideline:
- Model to predict either high or low fraction absorbed for an orally administered, passively transported substance on the basis of a new absorption parameter. The model includes only two inputs: the octanol-water partition coefficient (Kow) and the dimensionless oversaturation number (OLumen). The latter is the ratio of the concentration of drug delivered to the gastro-intestinal (GI) fluid to the solubility of the drug in that environment.
- Species:
- other: Human
- Type:
- absorption
- Results:
- Absorption from gastrointestinal tract for 1 mg dose: 95%
- Type:
- absorption
- Results:
- Absorption from gastrointestinal tract for 1000 mg dose: 90%
- Endpoint:
- dermal absorption, other
- Remarks:
- Mathematical simulation
- Type of information:
- calculation (if not (Q)SAR)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a (Q)SAR model, with limited documentation / justification, but validity of model and reliability of prediction considered adequate based on a generally acknowledged source
- Guideline:
- other: REACH Guidance on QSARs R.6
- Principles of method if other than guideline:
- IH SkinPerm mathematical tool for estimating dermal absorption
- Doses:
- 1000 mg/hour
- Time point:
- 8 h
- Dose:
- 1000 mg/hour
- Parameter:
- percentage
- Absorption:
- 0 %
- Endpoint:
- dermal absorption, other
- Remarks:
- QSAR
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a (Q)SAR model, with limited documentation / justification, but validity of model and reliability of prediction considered adequate based on a generally acknowledged source
- Guideline:
- other: REACH Guidance on QSARs R.6
- Principles of method if other than guideline:
- The Dermal Permeability Coefficient Program (DERMWIN) v2.00 estimates the dermal permeability coefficient (Kp), the dermally absorbed dose per event (DAevent) and Dermal Absorbed Dose (DAD) of organic compounds via water contact.
- Specific details on test material used for the study:
- CAS: 1999 -85 -5; SMILES : C(C)(C)(O)c1cc(C(C)(C)O)ccc1
CAS: 2948 -46 -1; SMILES : C(C)(C)(O)c1ccc(C(C)(C)O)cc1 - Parameter:
- rate
- Remarks:
- Kp
- Absorption:
- 0.001 cm/h
- Remarks on result:
- other: CAS: 1999-85-5
- Parameter:
- rate
- Remarks:
- Kp
- Absorption:
- 0.001 cm/h
- Remarks on result:
- other: CAS: 2948-46-1
Referenceopen allclose all
CAS: 1999 -85 -5
Kp (est): 0.00147 cm/hr
SMILES : C(C)(C)(O)c1cc(C(C)(C)O)ccc1
CHEM :
MOL FOR: C12 H18 O2
MOL WT : 194.28
------------------------------ Dermwin v2.01 ----------------------------------
Log Kow (estimated) : 2.31
Log Kow (user-entered): 1.60 (used in Kp calculations)
GENERAL Equation: log Kp = -2.80 + 0.66 log Kow - 0.0056 MW
Kp (predicted): 1.47e-003 cm/hr
Dermally Absorbed Dose per Event for Organic Compounds - Water Contact:
Water Conc (mg/cm3): 2 (estimated by program)
Fraction Absorbed : 1.0000
DA(event): 7.14e-003 mg/cm2-event (using eqn 3.2 & 3.3)
(tau = 1.31 hr, t* = 3.14 hr)
Dermally Absorbed Dose (70 kg Adult) - Water Contact:
DAD: 7.54e-001 mg/kg-day (using eqn 3.1)
----------------------------------------------------------------------------------------------------------------------------------------------
CAS: 2948 -46 -1
Kp (est): 0.00147 cm/hr
SMILES : C(C)(C)(O)c1ccc(C(C)(C)O)cc1
CHEM :
MOL FOR: C12 H18 O2
MOL WT : 194.28
------------------------------ Dermwin v2.01 ----------------------------------
Log Kow (estimated) : 2.31
Log Kow (user-entered): 1.60 (used in Kp calculations)
GENERAL Equation: log Kp = -2.80 + 0.66 log Kow - 0.0056 MW
Kp (predicted): 1.47e-003 cm/hr
Dermally Absorbed Dose per Event for Organic Compounds - Water Contact:
Water Conc (mg/cm3): 2 (estimated by program)
Fraction Absorbed : 1.0000
DA(event): 7.14e-003 mg/cm2-event (using eqn 3.2 & 3.3)
(tau = 1.31 hr, t* = 3.14 hr)
Dermally Absorbed Dose (70 kg Adult) - Water Contact:
DAD: 7.54e-001 mg/kg-day (using eqn 3.1)
Description of key information
No data on toxicokinetics, metabolism and distribution are available for m/p-DIOL.
Absorption
The assessment of the toxicokinetics of m/p-DIOL is based on the available toxicological data and the physicochemical properties of m/p-DIOL as suggested by the REACH Guidance Chapter R.7c.
The reaction mass is a white powder at room temperature with a molecular weight of 194.3 g/mol for the m/p-DIOL alone. The m/p-DIOL are soluble in water (2.66 g/L). The logKow of both meta and para DIOL is 1.6. Based on this log Kow a logBCF of 0.72 was calculated. The reaction mass of m/p-DIOL has a very low vapour pressure (0.2 Pa at 25 °C).
The powder is made of agglomerates of small particles, of few microns or tens of microns size (5-50 µm), plate shaped. The mean diameter of the test sample is determined to be close to 200 µm (the desagglomeration of the constitutive particles leads to a mean diameter measured at 69 µm).
Based on physico–chemical properties of m/p-DIOL, the substance is not likely to penetrate skin to a large extent as it is a powder. Nevertheless, after dissolution in an aqueous solution, the DIOL could penetrate the skin as their molecular weight, their water solubility and their Log Kow are rather in favor of dermal uptake. Therefore, the rate of absorption was estimated using the IH SkinPerm model using a Kp derived from the EPI Dermwin model. For a skin deposition of 1000 mg/h four 8 h, m/p-DIOL is virtually not absorbed (0%).
Based on the low vapour pressure and on the high granulometry, inhalation exposure is unlikely. Nevertheless, once in the respiratory tract, m/p-DIOL could be solubilized in contact of residual humidity, reach pulmonary alveoli and then be absorbed.
Based on the moderate solubility in water and in oil, the substance could be absorbed in a large extent following oral exposure. Using a model to predict either high or low fraction absorbed for an orally administered, passively transported substance, the rates of absorption were 95 and 90% for a dose of 1 and 1000 mg of m/p-DIOL, respectively.
Therefore, according to the REACH Guidance, default values of 100, 10 and 100% will be used for oral, dermal and inhalation absorptions of m/p-DIOL, respectively.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
